BlueCrest Capital Management »

Alnylam Pharmaceuticals shares owned by BlueCrest Capital Management

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by BlueCrest Capital Management from 13F filings

Historical chart of BlueCrest Capital Management investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by BlueCrest Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by BlueCrest Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $561k 1.2k 456.00
2018-09-30 $296k 3.4k 87.65
2017-12-31 $575k 4.5k 126.96
2017-09-30 $1.9M 16k 117.52
2017-06-30 $1.3M 16k 79.77
2015-12-31 $420k 4.5k 94.17

More positions owned by BlueCrest Capital Management

Spdr Gold Tr Gold Shs (GLD)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr S&p 100 Etf (OEF)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
PG&E Corporation (PCG)
Alphabet Cap Stk Cl A (GOOGL)
Crocs Call Option (CROX)
Spdr Series Trust S&p Oilgas Exp (XOP)
Amazon (AMZN)
Kraneshares Trust Csi Chi Internet (KWEB)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Meta Platforms Cl A (META)
Ishares Ethereum Tr SHS (ETHA)

View all positions for BlueCrest Capital Management

Top funds holding Alnylam Pharmaceuticals

FMR
Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
Jpmorgan Chase & Co
Groupama Asset Managment
State Street Corporation
Baillie Gifford & Co
Geode Capital Management
Dodge & Cox
T. Rowe Price Investment Management
Orbis Allan Gray
Wellington Management Company
Susquehanna International

View all funds holding Alnylam Pharmaceuticals